MENU

MRUS Merus NV Forecast, Technical & Fundamental Analysis

a developer of therapeutics for cancer treatment

Industry Biotechnology
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MRUS is expected to report earnings to fall 35.46% to -94 cents per share on March 04

Merus NV MRUS Stock Earnings Reports
Q4'24
Est.
$-0.94
Q3'24
Missed
by $0.60
Q2'24
Missed
by $0.05
Q1'24
Beat
by $0.22
Q4'23
Missed
by $0.27
The last earnings report on October 31 showed earnings per share of -146 cents, missing the estimate of -86 cents. With 414.77K shares outstanding, the current market capitalization sits at 3.07B.
A.I. Advisor
published General Information

General Information

a developer of therapeutics for cancer treatment

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Uppsalalaan 17
Phone
+31 302538800
Employees
229
Web
https://www.merus.nl
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

MRUS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MRUS has been loosely correlated with IMTX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if MRUS jumps, then IMTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRUS
1D Price
Change %
MRUS100%
+4.91%
IMTX - MRUS
34%
Loosely correlated
-1.24%
XENE - MRUS
34%
Loosely correlated
-0.07%
RCKT - MRUS
33%
Poorly correlated
+1.36%
ERAS - MRUS
30%
Poorly correlated
+0.38%
CGEM - MRUS
30%
Poorly correlated
-2.63%
More